ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Molecular Cloning Solutions Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-12V17370
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Molecular Cloning Solutions Market Research Report 2024
BUY CHAPTERS

Global Molecular Cloning Solutions Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-12V17370
Report
November 2025
Pages:131
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
VectorBuilder
BioServUK
GenScript
urofins Genomics
Innoprot
Genewiz
Bio-Fab Research
OriGene
Prospec-Tany Technogene
Addgene
Protein Ark
Protomnis
RD-Biotech
Charles River

Molecular Cloning Solutions Market

The global Molecular Cloning Solutions market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Molecular cloning service is a biotechnology service that aims to insert the target gene into a cloning vector through in vitro recombination methods to form a recombinant cloning vector, and replicate and amplify it in an appropriate host. In molecular cloning services, customers usually need to provide original samples, information about the target gene, and experimental requirements. The service provider is responsible for completing the entire molecular cloning process and providing high-quality clone products. These products can be used for subsequent gene function research, protein expression, virus packaging, cell therapy, mRNA vaccines and other applications.
From a downstream perspective, Laboratory accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Molecular Cloning Solutions leading manufacturers including VectorBuilder, BioServUK, GenScript, urofins Genomics, Innoprot, Genewiz, Bio-Fab Research, OriGene, Prospec-Tany Technogene, Addgene, etc., dominate supply; the top five capture approximately % of global revenue, with VectorBuilder leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Molecular Cloning Solutions market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Molecular Cloning Solutions Market Report

Report Metric Details
Report Name Molecular Cloning Solutions Market
Segment by Type
  • Restriction Enzyme Cloning
  • Primer Amplification Cloning
  • Gene Library Cloning
  • Gene Mutation Cloning
  • Genomic Cloning
Segment by Application
  • Laboratory
  • Research Institute
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company VectorBuilder, BioServUK, GenScript, urofins Genomics, Innoprot, Genewiz, Bio-Fab Research, OriGene, Prospec-Tany Technogene, Addgene, Protein Ark, Protomnis, RD-Biotech, Charles River
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Molecular Cloning Solutions study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Molecular Cloning Solutions Market report?

Ans: The main players in the Molecular Cloning Solutions Market are VectorBuilder, BioServUK, GenScript, urofins Genomics, Innoprot, Genewiz, Bio-Fab Research, OriGene, Prospec-Tany Technogene, Addgene, Protein Ark, Protomnis, RD-Biotech, Charles River

What are the Application segmentation covered in the Molecular Cloning Solutions Market report?

Ans: The Applications covered in the Molecular Cloning Solutions Market report are Laboratory, Research Institute, Others

What are the Type segmentation covered in the Molecular Cloning Solutions Market report?

Ans: The Types covered in the Molecular Cloning Solutions Market report are Restriction Enzyme Cloning, Primer Amplification Cloning, Gene Library Cloning, Gene Mutation Cloning, Genomic Cloning

1 Study Coverage
1.1 Introduction to Molecular Cloning Solutions: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Molecular Cloning Solutions Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Restriction Enzyme Cloning
1.2.3 Primer Amplification Cloning
1.2.4 Gene Library Cloning
1.2.5 Gene Mutation Cloning
1.2.6 Genomic Cloning
1.3 Market Segmentation by Application
1.3.1 Global Molecular Cloning Solutions Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Laboratory
1.3.3 Research Institute
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Molecular Cloning Solutions Revenue Estimates and Forecasts 2020-2031
2.2 Global Molecular Cloning Solutions Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Molecular Cloning Solutions Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Molecular Cloning Solutions Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Restriction Enzyme Cloning Market Size by Players
3.3.2 Primer Amplification Cloning Market Size by Players
3.3.3 Gene Library Cloning Market Size by Players
3.3.4 Gene Mutation Cloning Market Size by Players
3.3.5 Genomic Cloning Market Size by Players
3.4 Global Molecular Cloning Solutions Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Molecular Cloning Solutions Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Molecular Cloning Solutions Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Molecular Cloning Solutions Market Size by Type (2020-2031)
6.4 North America Molecular Cloning Solutions Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Molecular Cloning Solutions Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Molecular Cloning Solutions Market Size by Type (2020-2031)
7.4 Europe Molecular Cloning Solutions Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Molecular Cloning Solutions Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Molecular Cloning Solutions Market Size by Type (2020-2031)
8.4 Asia-Pacific Molecular Cloning Solutions Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Molecular Cloning Solutions Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Molecular Cloning Solutions Market Size by Type (2020-2031)
9.4 Central and South America Molecular Cloning Solutions Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Molecular Cloning Solutions Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Molecular Cloning Solutions Market Size by Type (2020-2031)
10.4 Middle East and Africa Molecular Cloning Solutions Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Molecular Cloning Solutions Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 VectorBuilder
11.1.1 VectorBuilder Corporation Information
11.1.2 VectorBuilder Business Overview
11.1.3 VectorBuilder Molecular Cloning Solutions Product Features and Attributes
11.1.4 VectorBuilder Molecular Cloning Solutions Revenue and Gross Margin (2020-2025)
11.1.5 VectorBuilder Molecular Cloning Solutions Revenue by Product in 2024
11.1.6 VectorBuilder Molecular Cloning Solutions Revenue by Application in 2024
11.1.7 VectorBuilder Molecular Cloning Solutions Revenue by Geographic Area in 2024
11.1.8 VectorBuilder Molecular Cloning Solutions SWOT Analysis
11.1.9 VectorBuilder Recent Developments
11.2 BioServUK
11.2.1 BioServUK Corporation Information
11.2.2 BioServUK Business Overview
11.2.3 BioServUK Molecular Cloning Solutions Product Features and Attributes
11.2.4 BioServUK Molecular Cloning Solutions Revenue and Gross Margin (2020-2025)
11.2.5 BioServUK Molecular Cloning Solutions Revenue by Product in 2024
11.2.6 BioServUK Molecular Cloning Solutions Revenue by Application in 2024
11.2.7 BioServUK Molecular Cloning Solutions Revenue by Geographic Area in 2024
11.2.8 BioServUK Molecular Cloning Solutions SWOT Analysis
11.2.9 BioServUK Recent Developments
11.3 GenScript
11.3.1 GenScript Corporation Information
11.3.2 GenScript Business Overview
11.3.3 GenScript Molecular Cloning Solutions Product Features and Attributes
11.3.4 GenScript Molecular Cloning Solutions Revenue and Gross Margin (2020-2025)
11.3.5 GenScript Molecular Cloning Solutions Revenue by Product in 2024
11.3.6 GenScript Molecular Cloning Solutions Revenue by Application in 2024
11.3.7 GenScript Molecular Cloning Solutions Revenue by Geographic Area in 2024
11.3.8 GenScript Molecular Cloning Solutions SWOT Analysis
11.3.9 GenScript Recent Developments
11.4 urofins Genomics
11.4.1 urofins Genomics Corporation Information
11.4.2 urofins Genomics Business Overview
11.4.3 urofins Genomics Molecular Cloning Solutions Product Features and Attributes
11.4.4 urofins Genomics Molecular Cloning Solutions Revenue and Gross Margin (2020-2025)
11.4.5 urofins Genomics Molecular Cloning Solutions Revenue by Product in 2024
11.4.6 urofins Genomics Molecular Cloning Solutions Revenue by Application in 2024
11.4.7 urofins Genomics Molecular Cloning Solutions Revenue by Geographic Area in 2024
11.4.8 urofins Genomics Molecular Cloning Solutions SWOT Analysis
11.4.9 urofins Genomics Recent Developments
11.5 Innoprot
11.5.1 Innoprot Corporation Information
11.5.2 Innoprot Business Overview
11.5.3 Innoprot Molecular Cloning Solutions Product Features and Attributes
11.5.4 Innoprot Molecular Cloning Solutions Revenue and Gross Margin (2020-2025)
11.5.5 Innoprot Molecular Cloning Solutions Revenue by Product in 2024
11.5.6 Innoprot Molecular Cloning Solutions Revenue by Application in 2024
11.5.7 Innoprot Molecular Cloning Solutions Revenue by Geographic Area in 2024
11.5.8 Innoprot Molecular Cloning Solutions SWOT Analysis
11.5.9 Innoprot Recent Developments
11.6 Genewiz
11.6.1 Genewiz Corporation Information
11.6.2 Genewiz Business Overview
11.6.3 Genewiz Molecular Cloning Solutions Product Features and Attributes
11.6.4 Genewiz Molecular Cloning Solutions Revenue and Gross Margin (2020-2025)
11.6.5 Genewiz Recent Developments
11.7 Bio-Fab Research
11.7.1 Bio-Fab Research Corporation Information
11.7.2 Bio-Fab Research Business Overview
11.7.3 Bio-Fab Research Molecular Cloning Solutions Product Features and Attributes
11.7.4 Bio-Fab Research Molecular Cloning Solutions Revenue and Gross Margin (2020-2025)
11.7.5 Bio-Fab Research Recent Developments
11.8 OriGene
11.8.1 OriGene Corporation Information
11.8.2 OriGene Business Overview
11.8.3 OriGene Molecular Cloning Solutions Product Features and Attributes
11.8.4 OriGene Molecular Cloning Solutions Revenue and Gross Margin (2020-2025)
11.8.5 OriGene Recent Developments
11.9 Prospec-Tany Technogene
11.9.1 Prospec-Tany Technogene Corporation Information
11.9.2 Prospec-Tany Technogene Business Overview
11.9.3 Prospec-Tany Technogene Molecular Cloning Solutions Product Features and Attributes
11.9.4 Prospec-Tany Technogene Molecular Cloning Solutions Revenue and Gross Margin (2020-2025)
11.9.5 Prospec-Tany Technogene Recent Developments
11.10 Addgene
11.10.1 Addgene Corporation Information
11.10.2 Addgene Business Overview
11.10.3 Addgene Molecular Cloning Solutions Product Features and Attributes
11.10.4 Addgene Molecular Cloning Solutions Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Protein Ark
11.11.1 Protein Ark Corporation Information
11.11.2 Protein Ark Business Overview
11.11.3 Protein Ark Molecular Cloning Solutions Product Features and Attributes
11.11.4 Protein Ark Molecular Cloning Solutions Revenue and Gross Margin (2020-2025)
11.11.5 Protein Ark Recent Developments
11.12 Protomnis
11.12.1 Protomnis Corporation Information
11.12.2 Protomnis Business Overview
11.12.3 Protomnis Molecular Cloning Solutions Product Features and Attributes
11.12.4 Protomnis Molecular Cloning Solutions Revenue and Gross Margin (2020-2025)
11.12.5 Protomnis Recent Developments
11.13 RD-Biotech
11.13.1 RD-Biotech Corporation Information
11.13.2 RD-Biotech Business Overview
11.13.3 RD-Biotech Molecular Cloning Solutions Product Features and Attributes
11.13.4 RD-Biotech Molecular Cloning Solutions Revenue and Gross Margin (2020-2025)
11.13.5 RD-Biotech Recent Developments
11.14 Charles River
11.14.1 Charles River Corporation Information
11.14.2 Charles River Business Overview
11.14.3 Charles River Molecular Cloning Solutions Product Features and Attributes
11.14.4 Charles River Molecular Cloning Solutions Revenue and Gross Margin (2020-2025)
11.14.5 Charles River Recent Developments
12 Molecular Cloning SolutionsIndustry Chain Analysis
12.1 Molecular Cloning Solutions Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Molecular Cloning Solutions Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Molecular Cloning Solutions Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
VectorBuilder
BioServUK
GenScript
urofins Genomics
Innoprot
Genewiz
Bio-Fab Research
OriGene
Prospec-Tany Technogene
Addgene
Protein Ark
Protomnis
RD-Biotech
Charles River
List of Tables
 Table 1. Global Molecular Cloning Solutions Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Molecular Cloning Solutions Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Molecular Cloning Solutions Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Molecular Cloning Solutions Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Molecular Cloning Solutions Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Molecular Cloning Solutions Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Molecular Cloning Solutions Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Molecular Cloning Solutions by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Cloning Solutions as of 2024)
 Table 11. Global Molecular Cloning Solutions Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Molecular Cloning Solutions Companies Headquarters
 Table 13. Global Molecular Cloning Solutions Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Molecular Cloning Solutions Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Molecular Cloning Solutions Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Molecular Cloning Solutions Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Molecular Cloning Solutions Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Molecular Cloning Solutions High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Molecular Cloning Solutions Growth Accelerators and Market Barriers
 Table 25. North America Molecular Cloning Solutions Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Molecular Cloning Solutions Growth Accelerators and Market Barriers
 Table 27. Europe Molecular Cloning Solutions Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Molecular Cloning Solutions Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Molecular Cloning Solutions Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Molecular Cloning Solutions Investment Opportunities and Key Challenges
 Table 31. Central and South America Molecular Cloning Solutions Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Molecular Cloning Solutions Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Molecular Cloning Solutions Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. VectorBuilder Corporation Information
 Table 35. VectorBuilder Description and Major Businesses
 Table 36. VectorBuilder Product Features and Attributes
 Table 37. VectorBuilder Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. VectorBuilder Revenue Proportion by Product in 2024
 Table 39. VectorBuilder Revenue Proportion by Application in 2024
 Table 40. VectorBuilder Revenue Proportion by Geographic Area in 2024
 Table 41. VectorBuilder Molecular Cloning Solutions SWOT Analysis
 Table 42. VectorBuilder Recent Developments
 Table 43. BioServUK Corporation Information
 Table 44. BioServUK Description and Major Businesses
 Table 45. BioServUK Product Features and Attributes
 Table 46. BioServUK Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. BioServUK Revenue Proportion by Product in 2024
 Table 48. BioServUK Revenue Proportion by Application in 2024
 Table 49. BioServUK Revenue Proportion by Geographic Area in 2024
 Table 50. BioServUK Molecular Cloning Solutions SWOT Analysis
 Table 51. BioServUK Recent Developments
 Table 52. GenScript Corporation Information
 Table 53. GenScript Description and Major Businesses
 Table 54. GenScript Product Features and Attributes
 Table 55. GenScript Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. GenScript Revenue Proportion by Product in 2024
 Table 57. GenScript Revenue Proportion by Application in 2024
 Table 58. GenScript Revenue Proportion by Geographic Area in 2024
 Table 59. GenScript Molecular Cloning Solutions SWOT Analysis
 Table 60. GenScript Recent Developments
 Table 61. urofins Genomics Corporation Information
 Table 62. urofins Genomics Description and Major Businesses
 Table 63. urofins Genomics Product Features and Attributes
 Table 64. urofins Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. urofins Genomics Revenue Proportion by Product in 2024
 Table 66. urofins Genomics Revenue Proportion by Application in 2024
 Table 67. urofins Genomics Revenue Proportion by Geographic Area in 2024
 Table 68. urofins Genomics Molecular Cloning Solutions SWOT Analysis
 Table 69. urofins Genomics Recent Developments
 Table 70. Innoprot Corporation Information
 Table 71. Innoprot Description and Major Businesses
 Table 72. Innoprot Product Features and Attributes
 Table 73. Innoprot Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Innoprot Revenue Proportion by Product in 2024
 Table 75. Innoprot Revenue Proportion by Application in 2024
 Table 76. Innoprot Revenue Proportion by Geographic Area in 2024
 Table 77. Innoprot Molecular Cloning Solutions SWOT Analysis
 Table 78. Innoprot Recent Developments
 Table 79. Genewiz Corporation Information
 Table 80. Genewiz Description and Major Businesses
 Table 81. Genewiz Product Features and Attributes
 Table 82. Genewiz Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Genewiz Recent Developments
 Table 84. Bio-Fab Research Corporation Information
 Table 85. Bio-Fab Research Description and Major Businesses
 Table 86. Bio-Fab Research Product Features and Attributes
 Table 87. Bio-Fab Research Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Bio-Fab Research Recent Developments
 Table 89. OriGene Corporation Information
 Table 90. OriGene Description and Major Businesses
 Table 91. OriGene Product Features and Attributes
 Table 92. OriGene Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. OriGene Recent Developments
 Table 94. Prospec-Tany Technogene Corporation Information
 Table 95. Prospec-Tany Technogene Description and Major Businesses
 Table 96. Prospec-Tany Technogene Product Features and Attributes
 Table 97. Prospec-Tany Technogene Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Prospec-Tany Technogene Recent Developments
 Table 99. Addgene Corporation Information
 Table 100. Addgene Description and Major Businesses
 Table 101. Addgene Product Features and Attributes
 Table 102. Addgene Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Addgene Recent Developments
 Table 104. Protein Ark Corporation Information
 Table 105. Protein Ark Description and Major Businesses
 Table 106. Protein Ark Product Features and Attributes
 Table 107. Protein Ark Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Protein Ark Recent Developments
 Table 109. Protomnis Corporation Information
 Table 110. Protomnis Description and Major Businesses
 Table 111. Protomnis Product Features and Attributes
 Table 112. Protomnis Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Protomnis Recent Developments
 Table 114. RD-Biotech Corporation Information
 Table 115. RD-Biotech Description and Major Businesses
 Table 116. RD-Biotech Product Features and Attributes
 Table 117. RD-Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. RD-Biotech Recent Developments
 Table 119. Charles River Corporation Information
 Table 120. Charles River Description and Major Businesses
 Table 121. Charles River Product Features and Attributes
 Table 122. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Charles River Recent Developments
 Table 124. Raw Materials Key Suppliers
 Table 125. Distributors List
 Table 126. Market Trends and Market Evolution
 Table 127. Market Drivers and Opportunities
 Table 128. Market Challenges, Risks, and Restraints
 Table 129. Research Programs/Design for This Report
 Table 130. Key Data Information from Secondary Sources
 Table 131. Key Data Information from Primary Sources


List of Figures
 Figure 1. Molecular Cloning Solutions Product Picture
 Figure 2. Global Molecular Cloning Solutions Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Restriction Enzyme Cloning Product Picture
 Figure 4. Primer Amplification Cloning Product Picture
 Figure 5. Gene Library Cloning Product Picture
 Figure 6. Gene Mutation Cloning Product Picture
 Figure 7. Genomic Cloning Product Picture
 Figure 8. Global Molecular Cloning Solutions Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 9. Laboratory
 Figure 10. Research Institute
 Figure 11. Others
 Figure 12. Molecular Cloning Solutions Report Years Considered
 Figure 13. Global Molecular Cloning Solutions Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Molecular Cloning Solutions Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Molecular Cloning Solutions Revenue Market Share by Region (2020-2031)
 Figure 17. Global Molecular Cloning Solutions Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. Restriction Enzyme Cloning Revenue Market Share by Player in 2024
 Figure 20. Primer Amplification Cloning Revenue Market Share by Player in 2024
 Figure 21. Gene Library Cloning Revenue Market Share by Player in 2024
 Figure 22. Gene Mutation Cloning Revenue Market Share by Player in 2024
 Figure 23. Genomic Cloning Revenue Market Share by Player in 2024
 Figure 24. Global Molecular Cloning Solutions Revenue Market Share by Type (2020-2031)
 Figure 25. Global Molecular Cloning Solutions Revenue Market Share by Application (2020-2031)
 Figure 26. North America Molecular Cloning Solutions Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Players Molecular Cloning Solutions Revenue (US$ Million) in 2024
 Figure 28. North America Molecular Cloning Solutions Revenue (US$ Million) by Type (2020 - 2031)
 Figure 29. North America Molecular Cloning Solutions Revenue (US$ Million) by Application (2020-2031)
 Figure 30. US Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 31. Canada Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 32. Mexico Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 33. Europe Molecular Cloning Solutions Revenue YoY (2020-2031) & (US$ Million)
 Figure 34. Europe Top 5 Players Molecular Cloning Solutions Revenue (US$ Million) in 2024
 Figure 35. Europe Molecular Cloning Solutions Revenue (US$ Million) by Type (2020-2031)
 Figure 36. Europe Molecular Cloning Solutions Revenue (US$ Million) by Application (2020-2031)
 Figure 37. Germany Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 38. France Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 39. U.K. Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 40. Italy Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 41. Russia Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 42. Asia-Pacific Molecular Cloning Solutions Revenue YoY (2020-2031) & (US$ Million)
 Figure 43. Asia-Pacific Top 8 Players Molecular Cloning Solutions Revenue (US$ Million) in 2024
 Figure 44. Asia-Pacific Molecular Cloning Solutions Revenue (US$ Million) by Type (2020-2031)
 Figure 45. Asia-Pacific Molecular Cloning Solutions Revenue (US$ Million) by Application (2020-2031)
 Figure 46. Indonesia Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 47. Japan Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 48. South Korea Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 49. Australia Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 50. India Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 51. Indonesia Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 52. Vietnam Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 53. Malaysia Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 54. Philippines Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 55. Singapore Molecular Cloning Solutions Revenue (2020-2031) & (US$ Million)
 Figure 56. Central and South America Molecular Cloning Solutions Revenue YoY (2020-2031) & (US$ Million)
 Figure 57. Central and South America Top 5 Players Molecular Cloning Solutions Revenue (US$ Million) in 2024
 Figure 58. Central and South America Molecular Cloning Solutions Revenue (US$ Million) by Type (2020-2031)
 Figure 59. Central and South America Molecular Cloning Solutions Revenue (US$ Million) by Application (2020-2031)
 Figure 60. Brazil Molecular Cloning Solutions Revenue (2020-2025) & (US$ Million)
 Figure 61. Argentina Molecular Cloning Solutions Revenue (2020-2025) & (US$ Million)
 Figure 62. Middle East and Africa Molecular Cloning Solutions Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Middle East and Africa Top 5 Players Molecular Cloning Solutions Revenue (US$ Million) in 2024
 Figure 64. South America Molecular Cloning Solutions Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Middle East and Africa Molecular Cloning Solutions Revenue (US$ Million) by Application (2020-2031)
 Figure 66. GCC Countries Molecular Cloning Solutions Revenue (2020-2025) & (US$ Million)
 Figure 67. Israel Molecular Cloning Solutions Revenue (2020-2025) & (US$ Million)
 Figure 68. Egypt Molecular Cloning Solutions Revenue (2020-2025) & (US$ Million)
 Figure 69. South Africa Molecular Cloning Solutions Revenue (2020-2025) & (US$ Million)
 Figure 70. Molecular Cloning Solutions Industry Chain Mapping
 Figure 71. Channels of Distribution (Direct Vs Distribution)
 Figure 72. Bottom-up and Top-down Approaches for This Report
 Figure 73. Data Triangulation
 Figure 74. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Laboratory Molecular Cloning Solutions Market Research Report 2024
Global Molecular Cloning Services Market Research Report 2024
Global Molecular Cloning Technology Services Market Research Report 2024
Global DNA Cloning Service Market Research Report 2025
Global DNA and Gene Cloning Services Market Research Report 2025
Global Plasmid Service Market Research Report 2024
Global Molecular Cloning Kit Market Research Report 2024
Global DNA Cloning Kit Market Research Report 2025
Global Custom Cloning Service Market Research Report 2025
Global Gene Cloning Service Market Research Report 2025
Global Molecular Biology Service Market Research Report 2025
Global Gene Cloning Technology Services Market Research Report 2024
Global Custom Gene Synthesis Service Market Research Report 2025
Global Gene Mutagenesis Service Market Research Report 2024
Global Cloning And Mutagenesis Market Research Report 2024
Global Protein Expression and Production Service Market Research Report 2024
Global In Vitro Transcription RNA Synthesis Service Market Research Report 2025
Global Gene Synthesis and Cloning Services Market Research Report 2024
Global Plasmid DNA Manufacturing Services Market Research Report 2025
Global Antibody Expression Service Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions